{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T17:57:03Z","timestamp":1772733423752,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,12]]},"DOI":"10.7759\/cureus.45079","type":"journal-article","created":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T09:29:38Z","timestamp":1694510978000},"source":"Crossref","is-referenced-by-count":2,"title":["Painful Small Fiber Neuropathy Associated With Teriflunomide: A Case Series and Literature Review Related to Teriflunomide and Leflunomide"],"prefix":"10.7759","author":[{"given":"Ahmed","family":"Elrefaey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anza B","family":"Memon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4103\/0972-2327.41875","article-title":"Diagnostic approach to peripheral neuropathy","volume":"11","author":"Misra UK","year":"2008","unstructured":"Misra UK, Kalita J, Nair PP. Diagnostic approach to peripheral neuropathy. Ann Indian Acad Neurol. 2008, 11:89-97. 10.4103\/0972-2327.41875","journal-title":"Ann Indian Acad Neurol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.984379","article-title":"High-resolution ultrasound of peripheral neuropathies in rheumatological patients: an overview of clinical applications and imaging findings","volume":"9","author":"Zaottini F","year":"2022","unstructured":"Zaottini F, Picasso R, Pistoia F, et al.. High-resolution ultrasound of peripheral neuropathies in rheumatological patients: an overview of clinical applications and imaging findings. Front Med (Lausanne). 2022, 9:984379. 10.3389\/fmed.2022.984379","journal-title":"Front Med (Lausanne)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2004.01.016","article-title":"Peripheral neuropathy in patients treated with leflunomide","volume":"75","author":"Bonnel RA","year":"2004","unstructured":"Bonnel RA, Graham DJ. Peripheral neuropathy in patients treated with leflunomide. Clin Pharmacol Ther. 2004, 75:580-5. 10.1016\/j.clpt.2004.01.016","journal-title":"Clin Pharmacol Ther"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S61651","article-title":"Teriflunomide for the treatment of relapsing-remitting multiple sclerosis: patient preference and adherence","volume":"9","author":"Bayas A","year":"2015","unstructured":"Bayas A, M\u00e4urer M. Teriflunomide for the treatment of relapsing-remitting multiple sclerosis: patient preference and adherence. Patient Prefer Adherence. 2015, 9:265-74. 10.2147\/PPA.S61651","journal-title":"Patient Prefer Adherence"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-014-0212-x","article-title":"Teriflunomide and its mechanism of action in multiple sclerosis","volume":"74","author":"Bar-Or A","year":"2014","unstructured":"Bar-Or A, Pachner A, Menguy-Vacheron F, Kaplan J, Wiendl H. Teriflunomide and its mechanism of action in multiple sclerosis. Drugs. 2014, 74:659-74. 10.1007\/s40265-014-0212-x","journal-title":"Drugs"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2015.11.006","article-title":"Pooled safety and tolerability data from four placebo-controlled teriflunomide studies and extensions","volume":"5","author":"Comi G","year":"2016","unstructured":"Comi G, Freedman MS, Kappos L, et al.. Pooled safety and tolerability data from four placebo-controlled teriflunomide studies and extensions. Mult Scler Relat Disord. 2016, 5:97-104. 10.1016\/j.msard.2015.11.006","journal-title":"Mult Scler Relat Disord"},{"key":"ref7","unstructured":"FDA Adverse Event Reporting System (FAERS) Public Dashboard. (2023). Accessed. April 20, 2023: https:\/\/www.fda.gov\/drugs\/questions-and-answers-fdas-adverse-event-reporting-system-faers\/fda-adverse-event-reporting...."},{"key":"ref8","unstructured":"Aubagio summary of product characteristics. (2023). Accessed. April 20, 2023: https:\/\/products.sanofi.us\/aubagio\/aubagio.pdf."},{"key":"ref9","article-title":"Peripheral neuropathy caused by leflunomide. A case reported with a brief review (Article in Spanish)","volume":"48","author":"Antonio-Valdiviezo A","year":"2010","unstructured":"Antonio-Valdiviezo A, Pe\u00f1a-Santos G, Mart\u00ednez-Torres J. Peripheral neuropathy caused by leflunomide. A case reported with a brief review (Article in Spanish). Rev Med Inst Mex Seguro Soc. 2010, 48:567-70.","journal-title":"Rev Med Inst Mex Seguro Soc"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh150","article-title":"Leflunomide-induced peripheral neuropathy: rapid resolution with cholestyramine wash-out","volume":"43","author":"Hill CL","year":"2004","unstructured":"Hill CL. Leflunomide-induced peripheral neuropathy: rapid resolution with cholestyramine wash-out. Rheumatology (Oxford). 2004, 43:809. 10.1093\/rheumatology\/keh150","journal-title":"Rheumatology (Oxford)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2005.08.021","article-title":"Leflunomide-induced peripheral neuropathy","volume":"14","author":"Kho LK","year":"2007","unstructured":"Kho LK, Kermode AG. Leflunomide-induced peripheral neuropathy. J Clin Neurosci. 2007, 14:179-81. 10.1016\/j.jocn.2005.08.021","journal-title":"J Clin Neurosci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/s0035-3787(05)85178-1","article-title":"Leflunomide-related severe axonal neuropathy (Article in French)","volume":"161","author":"Gabelle A","year":"2005","unstructured":"Gabelle A, Antoine JC, Hillaire-Buys D, Coudeyre E, Camu W. Leflunomide-related severe axonal neuropathy (Article in French). Rev Neurol (Paris). 2005, 161:1106-9. 10.1016\/s0035-3787(05)85178-1","journal-title":"Rev Neurol (Paris)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/41.8.952","article-title":"Peripheral neuropathy: an unwanted effect of leflunomide?","volume":"41","author":"Carulli MT","year":"2002","unstructured":"Carulli MT, Davies UM. Peripheral neuropathy: an unwanted effect of leflunomide?. Rheumatology (Oxford). 2002, 41:952-3. 10.1093\/rheumatology\/41.8.952","journal-title":"Rheumatology (Oxford)"},{"key":"ref14","unstructured":"Borrelli S, Lima JP, Dachy B. peripheral neuropathy as potential side effect of teriflunomide. (2021). Accessed: September 11, 2023: https:\/\/www.charcot-ms.org\/files\/05_ECF2021_Poster_CL_Borrelli_S.pdf."},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002441","article-title":"Long-term safety and efficacy of teriflunomide: nine-year follow-up of the randomized TEMSO study","volume":"86","author":"O'Connor P","year":"2016","unstructured":"O'Connor P, Comi G, Freedman MS, et al.. Long-term safety and efficacy of teriflunomide: nine-year follow-up of the randomized TEMSO study. Neurology. 2016, 86:920-30. 10.1212\/WNL.0000000000002441","journal-title":"Neurology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2018.6184","article-title":"Uridine 5'-diphospho-glucronosyltrasferase: its role in pharmacogenomics and human disease","volume":"16","author":"Sanchez-Dominguez CN","year":"2018","unstructured":"Sanchez-Dominguez CN, Gallardo-Blanco HL, Salinas-Santander MA, Ortiz-Lopez R. Uridine 5'-diphospho-glucronosyltrasferase: its role in pharmacogenomics and human disease. Exp Ther Med. 2018, 16:3-11. 10.3892\/etm.2018.6184","journal-title":"Exp Ther Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh191","article-title":"Peripheral neuropathy in patients on leflunomide","volume":"43","author":"Bharadwaj A","year":"2004","unstructured":"Bharadwaj A, Haroon N. Peripheral neuropathy in patients on leflunomide. Rheumatology (Oxford). 2004, 43:934. 10.1093\/rheumatology\/keh191","journal-title":"Rheumatology (Oxford)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/186076-painful-small-fiber-neuropathy-associated-with-teriflunomide-a-case-series-and-literature-review-related-to-teriflunomide-and-leflunomide","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:05:51Z","timestamp":1707509151000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/186076-painful-small-fiber-neuropathy-associated-with-teriflunomide-a-case-series-and-literature-review-related-to-teriflunomide-and-leflunomide"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,12]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.45079","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,12]]}}}